CCM
MRNA icon

Collar Capital Management’s Moderna MRNA Stock Holding History

Collar Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-49,686
Closed -$2.52M – 76
2026
Q1 		$2.52M Sell
49,686
-1,018
-2% -$47.5K 1.63% 28
2025
Q4 		$1.5M Buy
50,704
+12,139
+31% +$330K 1% 42
2025
Q3 		$996K Buy
38,565
+6,034
+19% +$168K 0.7% 49
2025
Q2 		$898K Sell
32,531
-2,154
-6% -$56.7K 0.76% 45
2025
Q1 		$983K Buy
34,685
+13,093
+61% +$465K 0.89% 47
2024
Q4 		$898K Buy
+21,592
New +$1.03M 0.75% 46

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Collar Capital Management's MRNA Position: Q2 2026 in Review

Collar Capital Management sold out of Moderna (MRNA) in Q2 2026, closing a stake of 49,686 shares — an estimated $2.52M sold.

Collar Capital Management first reported a position in MRNA in Q4 2024 and held it in 6 quarters. The position peaked at $2.52M in Q1 2026. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Collar Capital Management reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Collar Capital Management sold 49,686 Moderna shares in Q2 2026, an estimated $2.52M.
  • Collar Capital Management first reported a position in Moderna in Q4 2024 and held it in 6 quarters.
  • Collar Capital Management's Moderna position peaked at $2.52M in Q1 2026.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Collar Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.